Search Bar & Filters
Found 1 Actively Recruiting clinical trials
Actively Recruiting
Researchers are evaluating the effects of Reishi mushroom extract on fatigue and joint or muscle pain arthralgiasmyalgias in women with breast cancer who are taking aromatase inhibitors AIs. These symptoms are common during AI treatment and can affect quality of life or lead to stopping the medication early. The trial is a phase II study focused on supportive care for estrogen receptor-positive breast cancer patients. Reishi mushrooms have been traditionally used to support the immune system and reduce fatigue, but their effects on AI-related symptoms have not been specifically studied before. Participants are randomly assigned to one of two groups in a crossover design. One group receives 1,000 mg of Reishi mushroom extract orally three times daily for four weeks, followed by a placebo for four weeks. The other group starts with placebo for four weeks, then switches to the Reishi extract for the next four weeks. Treatment continues unless there is disease progression or unacceptable side effects. After completing the study treatments, participants are followed for 30 days to monitor safety. During the study, participants complete questionnaires to assess fatigue, pain, quality of life, and mood at the end of each treatment period and after crossover. Researchers also monitor treatment side effects through patient diaries and weekly phone calls. The main outcome is the change in fatigue scores after four weeks. Secondary outcomes include changes in pain, quality of life, mood, and adverse events up to 30 days post-treatment. Participants are expected to attend regular visits for assessments during the eight-week treatment phases and follow-up.